# Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm

> **NCT05121311** · — · COMPLETED · sponsor: **NeoPredix AG** · enrollment: 455 (actual)

## Conditions studied

- Newborn Jaundice

## Interventions

- **DIAGNOSTIC_TEST:** NeoprediX B1 algorithm

## Key facts

- **NCT ID:** NCT05121311
- **Lead sponsor:** NeoPredix AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-09
- **Primary completion:** 2021-11-30
- **Final completion:** 2022-01-31
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2022-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05121311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05121311, "Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05121311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*